Vijay Kumar is leaving his role as acting director of the office that reviews cell and gene therapies at the FDA, according ...

Today's health tech news includes virtual PT for a whole country, what the FDA is considering on AI policy, and more ...

When President Trump’s team of negotiators got Eli Lilly and Novo Nordisk to agree to a monthly $245 price in Medicare and ...

Anthropic released Claude Science, an application that optimizes its large language model for scientists and, especially, ...

Hofmann is a fourth-year medical student in the M.D./M.P.H. dual degree program at the University of Miami Miller School of ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Abivax on Monday night ...

Vijay Kumar, acting director of the office that reviews cell and gene therapies at the Food and Drug Administration, is ...

Theresa is the lead Morning Rounds writer, and her stories focus on gender-affirming care, reproductive health, and mental health. You can reach Theresa on Signal at theresagaff.97. Get your daily ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. WASHINGTON — The chair of the ...

Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...